Delivery Order SPE2DB25D9348-SPE2DB25FNMVY
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency on September 9, 2025, for the supply of Lenvima 10 mg daily dose tablets (30-count packaging). The contract carries an ultimate completion date of September 30, 2025, and includes no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency (DLA) on September 16, 2025. The contract calls for the delivery of Lenvima 20 mg daily dose tablets in quantities of 60 units, with an ultimate completion date of October 7, 2025. This delivery order was issued without a set-aside designation, leveraging the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency for the supply of Lenvima 14 mg daily dose medication in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, is scheduled for completion by October 1, 2025, with no set-aside designation applied. The award represents a continuation of DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for LENVIMA 8 mg daily dose medication (60-count supply). The contract is valued at $29,624.58 and operates under a firm fixed-price delivery order structure with an ultimate completion date of October 8, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency on August 28, 2025, for the supply of Lenvima 14 mg daily dose tablets in quantities of 60 units. The contract carries an ultimate completion date of September 19, 2025, and does not utilize a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,353.77 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Lenvima 14 mg daily dose medication in 60-count quantities. This firm fixed-price delivery order is expected to be completed by September 23, 2025, with performance taking place at the contractor's Park Ridge facility. The award was made without a...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 8 mg daily dose tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025. The contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $34,061.31 to DMS Pharmaceutical Group Inc. for the supply of Lenvima 8 mg daily dose tablets (60-count). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location with an ultimate completion date of October 6, 2025. This award was made without a set-aside designation, and the contract was...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $124,891.53 for LENVIMA 20 mg daily dose medication (60-unit supply) by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. This delivery order, which carries no set-aside designation, is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for LENVIMA 18 mg daily dose medication (90-unit supply) with a ceiling value of $22.7K. The award, issued on September 10, 2025, utilizes a firm fixed-price contract structure with an ultimate completion date of October 1, 2025. This delivery order carries no set-aside designation, allowing DMS Pharmaceutical...
- SPE2DB25D9348Indefinite Delivery Contract
- SPE2DB25D9348-SPE2DB25FNMVYDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,353.77 by the Defense Logistics Agency on August 22, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count). This firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance taking place at the vendor's Park Ridge location. The award was made without a set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement markets. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting Department of Defense healthcare facilities. As a established supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables distributed to military health facilities nationwide. Lenvima, a prescription medication used in oncology treatments, represents one of the specialized pharmaceutical products within the company's contracted product range.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 8/22/25 |